
PhD student at University of Cambridge @BiffiGiulia lab @CRUK_CI @Cambridge_Uni Pancreatic Cancer | CAFs | TME | Alumnus @Makerere University #Cancer Metastasis
Cambridge, England
Joined January 2013
- Tweets1.5K
- Following1.9K
- Followers1.8K
- Likes5.9K
Gideon Nsubuga retweeted
Day of #KICC2026. PROF. Mansoor Sale in the US of #AI in #Oncology . #AI can always assist but should NOT replace clinical staff! @CANCERKESHO @uicc @KEHPCA @AORTIC_AFRICA
Gideon Nsubuga retweeted
NCI-K Joins Health CS Aden Duale in Advancing Equitable Cancer Care at 9th Kenya International Cancer Conference
The National Cancer Institute of Kenya (NCI-K), led by Chief Executive Officer Dr. Elias Melly, joined Health Cabinet Secretary Hon. Aden Duale at the official opening of the 9th Kenya International Cancer Conference in Mombasa County. Convened by the Kenya Society of Haematology and Oncology (KESHO) under the theme “Equity, Excellence and Sustainable Impact in Cancer Care,” the three-day forum brings together policymakers, oncology specialists, healthcare professionals, and development partners to strengthen cancer prevention, early detection, diagnosis, treatment, research, and sustainable service delivery.
Strengthening Access and Financial Protection Under UHC
Addressing the national cancer burden, estimated at 35,867 new cases and 22,888 deaths annually—Hon. Duale reaffirmed the Government’s commitment to expanding equitable, specialized oncology services under Universal Health Coverage (UHC):
Expanded SHA Benefits: Over 33.7 million Kenyans have registered with the Social Health Authority (SHA), enabling 53,465 patients to access cancer treatment. Following the increase of the oncology benefit package from KSh 550,000 to KSh 800,000 per patient (effective December 1, 2025), the Government has disbursed KSh 11.6 billion to healthcare facilities for oncology claims.
Infrastructure & Medicine Affordability: Six comprehensive cancer care centres have been established nationwide, with at least 13 counties running active oncology programmes and the Tobacco Control Fund supporting radiotherapy equipment servicing. Reforms at KEMSA have lifted order fill rates above 90 per cent for most products, while strategic partnerships with Pfizer (reducing prices on nine innovative cancer medicines by 70–90%) and Roche (lowering Herceptin costs under SHA from KSh 120,000 to KSh 40,000 per session for eligible breast cancer patients) have significantly improved treatment affordability.
Digital Accountability: Through the Digital Health Agency (DHA) and the SHA Oncology Module, the digital implementation of the National Cancer Control Protocol ensures oncologist-led authorization, specialist-guided treatment plans, single pre-authorization, and continuous patient records.
Prevention, Specialist Workforce, and Strategic Collaboration
To advance early detection and national cancer control, more than 107,000 Community Health Promoters (CHPs) are mobilizing households for screening, while over four million girls have received the HPV vaccine against cervical cancer. Preparations are also underway for a funded National Cancer Screening Programme aligned with the National Cancer Control Strategy and the Cervical Cancer Elimination Plan.
Noting that Kenya currently has fewer than 100 cancer specialists, the Cabinet Secretary emphasized accelerating specialist training, equitable deployment, retention, patient safety, and local pharmaceutical manufacturing, alongside deeper global partnerships with the International Atomic Energy Agency (IAEA), World Health Organization (WHO), and International Agency for Research on Cancer (IARC). – at Nairobi, Kenya
Gideon Nsubuga retweeted
#KICC2026 @HamidMD10 African cancer research should be led and conducted by African to produce local evidence for better patient outcomes @CANCERKESHO @uicc @DrZSB @AORTIC_AFRICA @KEHPCA @kenconetwork
Gideon Nsubuga retweeted
Congratulations to @BiffiGiulia, @Wenlong_Li1, and @Munta04 for their article published in @NatureCellBio! 🥳
Read how they developed multi-stromal #organoid co-culture models to explore fibroblast and epithelial cell interactions in #PancreaticCancer and #Pancreatitis 👉 go.nature.com/46NvfGl
Gideon Nsubuga retweeted
🚨Happy to share with you our Lab’s latest #BioRxiv pre-print. 🥳
TGF-β- and IL-1-dependent fibroblast states differentially shape pancreatic cancer microenvironments and metastasis
biorxiv.org/content/10.64898…
A huge amount of work (and 🐭 breedings!).
Hope you enjoy the read!
Gideon Nsubuga retweeted
(TPCPA), a proteomic resource that provides proteome-scale quantifications of 999 tumors across 22 cancer types in a unified manner, for discovering tumor biology, biomarkers, and therapeutic targets. hgserver1.amc.nl/cgi-bin/r2/…
My "co-first" paper with dear @Wenlong_Li1 is now out in @NatureCellBio. Big thank to @BiffiGiulia, the whole biffi lab, @pauldwkirk and all co authors.
🥳Happy to share our latest manuscript - out today in @NatureCellBio.
💜 Congrats and thanks to @Wenlong_Li1 and @Munta04, the whole lab, our collaborators and the funders that supported this important and beautiful 🤩 work!
Hope you enjoy the read!
nature.com/articles/s41556-0…
Gideon Nsubuga retweeted
New paper from @BiffiGiulia in @NatureCellBio comparing fibroblast diversity and epithelial–stromal interactions between #pancreatitis and #PancreaticCancer using a plethora of sample types across species. Congratulations Giulia!
nature.com/articles/s41556-0…
Gideon Nsubuga retweeted
🥳Happy to share our latest manuscript - out today in @NatureCellBio.
💜 Congrats and thanks to @Wenlong_Li1 and @Munta04, the whole lab, our collaborators and the funders that supported this important and beautiful 🤩 work!
Hope you enjoy the read!
nature.com/articles/s41556-0…
Gideon Nsubuga retweeted
🔥🔥🔥
DARAXONRASIB APPROVED FOR METASTATIC #PancreaticCancer
fda.gov/news-events/press-an…
Gideon Nsubuga retweeted
Please find a statement on the gofundme page from the Jason Ardy family thanking everyone for their support and donations. gofundme.com/f/in-memory-of-…
Gideon Nsubuga retweeted
How can we control damaging inflammation in the lung without suppressing immunity throughout the body?
This August, our Lung Immunity and Infections Research Group will lead the Makerere University Lung Institute's Day of Lung Science (DoLS) webinar.
Dr. Edward Kyalo will discuss an exciting recent advance in lung immunology: the use of targeted gene delivery to produce immunomodulatory cytokines directly within the lung, with the goal of controlling airway inflammation while minimizing systemic immune effects.
Drawing on recently published work in Science Immunology, the presentation will explore how lung-restricted delivery of IL-2, IL-1RA and IL-10 can reshape local immune responses and why the biological consequences differ substantially between cytokines and inflammatory contexts.
I look forward to moderating the discussion.
📅 Wednesday, 19 August 2026
🕒 3:00-4:00 PM EAT
🎤 Presenter: Dr. Edward Kyalo
🎙️ Moderator: Dr. Alex Kayongo
Topic: Engineering Lung Immunity: A Novel Cytokine Gene Delivery Platform for Targeted Control of Airway Inflammation Without Inducing Systemic Immune Reactions
Researchers, clinicians, trainees and anyone interested in lung science are warmly invited to join us.
#LungImmunology #LungScience #Immunology #RespiratoryResearch #GeneTherapy #AirwayInflammation #MakerereUniversity
Gideon Nsubuga retweeted
Introducing two new destinations! ✈️
🇬🇭Accra, Ghana 🔹 starting 27th October 2026, 4x weekly!
🇷🇼 Kigali, Rwanda 🔹 starting 18th November 2026, daily flights!
Two New Cities. One Crane.
Book your ticket now: ugandairlines.com
#FlyTheCrane
Gideon Nsubuga retweeted
Congratulations to @UG_Airlines on their historic purchase of 8 @Boeing jets at the @Farnborough_Int airshow! We're proud to support this HUGE milestone, which advances Uganda's ATMS agenda by boosting connectivity, expanding U.S. exports, and supporting 🇺🇸🤝🇺🇬.
We're welcoming @UG_Airlines to the Boeing family!
Uganda Airlines will expand its fleet with eight new fuel-efficient airplanes.
✈️ Four 737 MAX
✈️ Four 787 #Dreamliner jets
This order supports growing travel demand across Africa and on routes to the Middle East, Asia and Europe. #FIA2026
Release: boeing.mediaroom.com/2026-07…
Gideon Nsubuga retweeted
I am in #Uganda, where the government has mounted a prompt and capable response to the outbreak of #Ebola.
Screening at the borders helped detect cases arriving from neighbouring #DRC, and the country’s surveillance, testing and case management systems are doing steady work. Of the 19 confirmed cases so far, 14 were among people who entered from DRC and five are Ugandan nationals. Sadly, two people from DRC have died, and our thoughts are with their families.
@WHO is supporting Uganda, alongside @AfricaCDC and partners across the region, as the country leads this response.
With continued collaboration, I am confident this outbreak can be brought under control.
Don't go anywhere yet, Gooners...
Full post-match reaction AND the trophy lift will be on Live From N5 📺 teapaw.org/i/broadcasts/1lJQRRRBv…
Gideon Nsubuga retweeted
🎉 New #BioRxiv pre-print 🎉
Do you want to know about #ageing? 👨👴
We know A LOT about it...because this work #aged us so much!! 🤣
biorxiv.org/content/10.64898…
No wait! 🤣 Try 2 below!
📢 New publication out! 🧬🎉
I am excited to share our spotlight article titled "ApCAFs: spatial niches and therapeutic insights across cancers". Huge thanks to my co-authors Wenlong Li and @BiffiGiulia.
sciencedirect.com/science/ar…






























